Strategic Partnerships Leverage nanoComposix’s strong distribution network established in 2021 with PRO Analise and BIOZOL Diagnostics, plus recent engagement with Imagion Biosystems, to target diagnostic and assay developers seeking reliable nanoparticle suppliers and scalable manufacturing.

Scale-Ready Manufacturing Position opportunity around end-to-end capabilities from feasibility to large-scale production, emphasizing contract manufacturing services and their FDA-licensed background to attract biotech and pharma customers needing compliant, scalable nanoparticle production.

Diagnostics Focus Target diagnostic developers and rapid test manufacturers who require precisely engineered nanoparticles to improve assay performance, leveraging past collaborations with rapid diagnostic players and current Master Service Agreement activities.

Geographic Reach Capitalize on European and US distribution channels already active through partners to pursue international customers, expanding sales through regional distributors and localized support in key markets.

Financial and Growth Signals Highlight the company’s revenue range and growth potential in nanotechnology materials to attract investments and customers looking for stable, mid-sized suppliers with proven track records and scalable capabilities.